Award recordCONTRACT

ADVANCED ACCELERATOR APPLICATIONS USA INC

PIID 36C24926N0263· VHA· 249-NETWORK CONTRACT OFFICE 9 (36C249)· 6505 · DRUGS AND BIOLOGICALS· FY2026· $823,062 net obligations· UEI JNM4NBNHFE66· NY

Description

VISN RADIOPHARMACEUTICAL PLUVICTO DRUG TVHS INC MOD

Base award description: VISN PADIOPHARMACEUTICAL PLUVICTO DRUG

First action · last action
2025-12-16 · 2026-08-10
Transactions
5
First transaction's obligation
$2,366,304
Base + all options value (sum of deltas)
$5,006,962
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C24925A0031
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 5 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$2,915,012$0Base award · 2025-12-16 · this action $2,366,304 · running total $2,366,304Modification P00001 · 2026-04-01 · this action $102,883 · running total $2,469,187Modification P00002 · 2026-04-21 · this action $102,883 · running total $2,572,070Modification P00003 · 2026-06-10 · this action $342,943 · running total $2,915,012Modification P00004 · 2026-08-10 · this action -$2,091,950 · running total $823,062
  • Base2025-12-16+$2,366,304= $2,366,304
  • Mod P000012026-04-01+$102,883= $2,469,187
  • Mod P000022026-04-21+$102,883= $2,572,070
  • Mod P000032026-06-10+$342,943= $2,915,012
  • Mod P000042026-08-10-$2,091,950= $823,062
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2025-12-16+$2,366,304$2,366,304VISN PADIOPHARMACEUTICAL PLUVICTO DRUG
Mod P00001· FUNDING ONLY ACTION2026-04-01+$102,883$2,469,187VISN PADIOPHARMACEUTICAL PLUVICTO DRUG
Mod P00002· FUNDING ONLY ACTION2026-04-21+$102,883$2,572,070VISN RADIOPHARMACEUTICAL PLUVICTO DRUG TVHS INC MOD
Mod P00003· FUNDING ONLY ACTION2026-06-10+$342,943$2,915,012VISN RADIOPHARMACEUTICAL PLUVICTO DRUG TVHS INC MOD
Mod P00004· FUNDING ONLY ACTION2026-08-10−$2,091,950$823,062VISN RADIOPHARMACEUTICAL PLUVICTO DRUG TVHS INC MOD

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JNM4NBNHFE66)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0132255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$1,200,000FY2026
36C26026N0121260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$996,874FY2026
36C25525N0282255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$166,146FY2025
36C25525N0176255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$1,362,395FY2025
36C25225F0044252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$631,354FY2025
36C26025N0127260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$232,604FY2025

Other recipients under 6505 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24926N0676AMICUS THERAPEUTICS US, LLC249-NETWORK CONTRACT OFFICE 9 (36C249)$68,519FY2026
36C24926N0651BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$378,650FY2026
36C24926N0658BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026
36C24926N0590BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026
36C24926N0589BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24926N0263_3600_36C24925A0031_3600 · retrieved 2026-09-26.